ERP OperationsFree Interactive Tool

FDA 21 CFR Part 11 Readiness Assessment: Score Your Electronic Records Compliance

21 CFR Part 11 inspections do not fail on intent, they fail on evidence: can you show a complete, tamper-evident audit trail for the electronic record an investigator picked, and can you produce it fast. This 8-question assessment scores your organization across e-signature validity, audit trail coverage, access control, validation currency, and data integrity monitoring, then places you in one of four readiness bands with specific next steps. It takes under five minutes and gives medical device makers and regulated manufacturers a documented starting point before the next FDA inspection or customer quality audit.

0 of 8 answered0%

1. How are electronic records for GxP-regulated processes signed and approved?

Consider batch records, quality records, and any document requiring a formal approval signature.

2. Do your systems maintain a secure, computer-generated, time-stamped audit trail of record creation, modification, and deletion?

3. How is system access controlled for users who can create or modify electronic records?

4. What is your validation status for computer systems used in regulated processes (CSV or risk-based CSA)?

5. How do you handle data integrity controls consistent with ALCOA+ principles across your quality systems?

6. What is your process for detecting and investigating data integrity or audit trail anomalies?

7. How prepared is your organization to produce a complete electronic record and audit trail package on FDA request?

Assume a request for a full record set with supporting audit trail across a specific date range.

8. Has your quality or IT team conducted a gap assessment against 21 CFR Part 11 in the last 12 months?

Audit trail completeness is the single most common finding

FDA 483 observations related to Part 11 disproportionately cite incomplete or missing audit trails, particularly for systems that were added after the original validation was completed. A shop floor MES upgrade, a new LIMS integration, or a spreadsheet-based workaround for a gap in the primary system are all common sources of audit trail blind spots that investigators specifically look for.

  • Audit trail gaps are easier to find during inspection than during internal review
  • Spreadsheet workarounds outside the validated system are a frequent, avoidable finding
  • Every system touching a GxP record needs the same audit trail standard, not just the primary one

Validation currency matters as much as validation existence

Having a validation package on file is not the same as being validated today. System updates, patches, and configuration changes that are not re-evaluated against the original validation create a documentation gap that investigators treat as equivalent to no validation at all. Risk-based Computer Software Assurance approaches can keep this current without re-running a full validation cycle for every minor change.

  • Any patch or configuration change should trigger a documented impact assessment
  • Risk-based CSA lets you scale validation effort to the actual risk of the change
  • Outdated validation documentation is treated the same as missing validation by investigators

Speed of response is itself a compliance signal

How quickly you can produce a complete electronic record with its audit trail on request signals the maturity of your entire program to an investigator, independent of whether any single control has a gap. Organizations that need weeks to assemble a record set invite deeper scrutiny into every other control, while same-day production builds confidence that carries through the rest of the inspection.

  • Same-day record production is achievable with automated export tooling
  • Slow response to a record request is itself logged as an observation in some inspections
  • A documented, tested record retrieval process is worth building before you need it

Frequently Asked Questions

What is 21 CFR Part 11 and who does it apply to?

21 CFR Part 11 is the FDA regulation governing electronic records and electronic signatures used in place of paper records for FDA-regulated processes. It applies to any company, including medical device makers, pharmaceutical manufacturers, and their suppliers, that uses electronic systems to create, modify, or store GxP records.

What is the difference between traditional CSV and risk-based CSA?

Traditional Computer System Validation applies a uniform, exhaustive validation protocol to every system regardless of risk. Risk-based Computer Software Assurance scales validation effort to the actual patient safety and data integrity risk of the system, letting low-risk changes move faster while still documenting the assessment.

What triggers an FDA 483 observation related to Part 11?

The most common triggers are incomplete or missing audit trails, shared or generic system logins, outdated validation documentation after a system change, and an inability to produce a complete record set promptly on request. Investigators specifically probe for gaps introduced by system updates made after initial validation.

How long should audit trail data be retained under Part 11?

Part 11 itself does not set a universal retention period; retention is governed by the predicate rule for the specific record type, such as device history records or batch records, which commonly range from several years to the life of the product plus additional years. Retention policy should be documented per record class.

Can spreadsheets be used for GxP records under Part 11?

Spreadsheets can be used only if they meet the same validation, audit trail, and access control requirements as any other system handling GxP records, which most standard spreadsheet deployments do not meet without significant additional controls. Investigators frequently flag ad hoc spreadsheet use as an unvalidated system finding.

Netray builds validated data pipelines and automated audit trail systems for medical device makers and regulated manufacturers, so a record request is a five-minute export instead of a two-week scramble.